Latest Breaking News On - Samer srour - Page 2 : comparemela.com

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatmen

– Orca-T, Orca Bio’s lead investigational high-precision cell therapy, showed similar results in older patients undergoing myeloablative conditioning as seen in younger patients across disease control, non-relapse mortality and overall survival –– Orca-T in older patients given a reduced intensity conditioning regim.

United statesJoshua murraySamer srourIvan dimovKelsey grossmanDepartment of stem cell transplantationDrug administrationCorporate communicationsUniversity of texas md anderson cancer centerAmerican society of hematologyBone marrow transplantation stem cell processing centerOrca bioAmerican societyAnnual meetingOlder patientsCaspian oliai

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJoshua murrayIvan dimovSamer srourKelsey grossmanUniversity of texas md anderson cancer centerDrug administrationCorporate communicationsBone marrow transplantation stem cell processing centerDepartment of stem cell transplantationAmerican society of hematologyOrca bioAmerican societyAnnual meetingOlder patientsCaspian oliai

Orca Bio Presents Positive Data Demonstrating the Potential for Orca-T and Orca-Q to Expand Treatment to Additional Patient Groups at the 65th ASH Annual Meeting

Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.

New yorkUnited statesNorth vancouverBritish columbiaGabriel friedmanJoshua murraySamer srourBarbara shecterKelsey grossmanHoward levittIvan dimovJoe oconnorNational postUniversity of texas md anderson cancer centerCorporate communicationsDepartment of stem cell transplantation

FDA Grants Fast Track Designation to IVS-3001 for Renal Cell Carcinoma

The FDA has granted fast track designation IVS-3001 for use as a potential therapeutic option in patients with renal cell carcinoma.

United statesSamer srourJake kushnerMaung naingInvectys incUniversity of texas md anderson cancer centerCancer centerInvestigational cancer therapeuticsStem cell transplantationCellular therapyIvs 3001Patients with renal cell carcinomaThe university of texas md anderson cancer center

Invectys Announces Initiation of Phase 1/2a Clinical Trial in Solid Tumors and Change in Leadership

Invectys Announces Initiation of Phase 1/2a Clinical Trial in Solid Tumors and Change in Leadership
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Baylor college of medicineUnited statesPasteur instituteFrance generalJulien caumartinSamer srourJake kushnerRosie williamsMaung naingInvectys incInvectys united states incResearch institute of texasResearch institute of texas grantAnnounces initiationClinical trialSolid tumors